Outcomes of Patients with Splenic Marginal Zone Lymphoma Treated with Rituximab or Splenectomy: Report from Tertiary Cancer Center in India

被引：0
|
作者：
Bagal, Bhausaheb [1 ]
Mandal, Tanmoy [1 ]
Bonda, Avinash [1 ]
Punatar, Sachin [1 ]
Gokarn, Anant [1 ]
Tembhare, Prashant [1 ]
Jain, Hasmukh [1 ]
Patkar, Nikhil [1 ]
Epari, Sridhar [1 ]
Sengar, Manju [1 ]
Khattry, Navin [1 ]
Shet, Tanuja [1 ]
Gujral, Sumit [1 ]
Banavali, Shripad [1 ]
机构：
[1] Tata Mem Hosp, Bombay, Maharashtra, India
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
Splenic marginal zone lymphoma; Splenectomy; Rituximab;
D O I：
10.1016/j.clml.2018.07.216
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NHL-185
引用
收藏
页码：S282 / S283
页数：2
相关论文
共 50 条
  • [21] Treatment of Splenic Marginal Zone Lymphoma with Rituximab Monotherapy in 59 Patients
    Kalpadakis, Christina H.
    Pangalis, Gerassimos
    Vassilakopoulos, Theodoros P.
    Sachanas, Sotirios P.
    Kontopidou, Flora
    Yiakoumis, Xanthi
    Kokoris, Styliani
    Dimitriadou, Evangelia
    Dimopoulou, Maria
    Moschogiannis, Maria
    Korkolopoulou, Penelope
    Kyrtsonis, Marie-Christine
    Siakantaris, Marina
    Papadaki, Helen A.
    Angelopoulou, Maria K.
    BLOOD, 2011, 118 (21) : 1167 - 1167
  • [22] Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia
    Xing, Katharine H.
    Kahlon, Amrit
    Skinnider, Brian F.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Sehn, Laurie H.
    Savage, Kerry J.
    Slack, Graham W.
    Shenkier, Tamara N.
    Klasa, Richard
    Gerrie, Alina S.
    Villa, Diego
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (04) : 520 - 527
  • [23] Increased toxicities in children with Burkitt lymphoma treated with rituximab: Experience from a tertiary cancer center in India
    Srinivasan, Shyam
    Roy Moulik, Nirmalya
    Anand, K. C.
    Narula, Gaurav
    Sankaran, Hari
    Prasad, Maya
    Dhamne, Chetan
    Cheriyalinkal Parambil, Badira
    Shah, Sneha
    Shet, Tanuja
    Sridhar, Epari
    Gujral, Sumeet
    Banavali, Shripad
    PEDIATRIC BLOOD & CANCER, 2020, 67 (11)
  • [24] Rituximab monotherapy for splenic marginal zone lymphoma with villous lymphocytes: report on long-term disease control for two patients with recurrence after splenectomy
    Debiasi, Marcio
    Hehnemann, Marluce
    Garicochea, Bernardo
    SAO PAULO MEDICAL JOURNAL, 2010, 128 (06): : 375 - 377
  • [25] Patients with marginal zone dural lymphoma successfully treated with rituximab and bendamustine: A report of two cases
    Tsutsumi, Yutaka
    Ito, Shinichi
    Nagai, Jun
    Tateno, Takahiro
    Teshima, Takanori
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (04)
  • [26] Not Yet Time to Retire Splenectomy in Splenic Marginal Zone Lymphoma (SMZL): Results of a Single Center Experience
    Anastasia, Antonella
    Pagani, Chiara
    Re, Alessandro
    Motta, Marina
    Pata, Giacomo
    Damiani, Enrico
    Gandolfi, Lisa
    Daffini, Rosa
    Tucci, Alessandra
    BLOOD, 2022, 140 : 11951 - 11953
  • [27] Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy A case report
    Ishiguro, Kazuya
    Sasaki, Yasushi
    Takagi, Yoshitake
    Niinuma, Takeshi
    Suzuki, Hiromu
    Tokino, Takashi
    Hayashi, Toshiaki
    Takahashi, Tohru
    Igarashi, Tetsuyuki
    Matsuno, Yoshihiro
    MEDICINE, 2020, 99 (35)
  • [28] Outcomes of surgically treated oral cancer patients at a tertiary cancer center in India
    Nair, Deepa
    Singhvi, Hitesh
    Mair, Manish
    Qayyumi, Burhanuddin
    Deshmukh, Anuja
    Pantvaidya, Gouri
    Nair, Sudhir
    Chaturvedi, Pankaj
    Laskar, Sarbani Ghosh
    Prabhash, Kumar
    DCruz, Anil
    INDIAN JOURNAL OF CANCER, 2017, 54 (04) : 616 - 620
  • [29] Optimal Rituximab Monotherapy in Splenic Marginal Zone Lymphoma (SMZL): A Case Report and Brief Review
    Guan, Rong-Yan
    Tang, Xing-Ru
    Huang, Zou-Fang
    Du, Jun
    Fu, Xue-Hang
    Lu, Guang
    Mou, Wei-Wei
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2025, 20 (01) : 121 - 130
  • [30] TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA (SMZL) IN A SERIES OF 78 PATIENTS: FROM WATCH AND WAIT TO RITUXIMAB MONOTHERAPY
    Kalpadakis, C.
    Pangalis, G. A.
    Vassilakopoulos, T. P.
    Dimopoulou, M. N.
    Kyrtsonis, M. C.
    Korkolopoulou, P.
    Korkolopoulou, P.
    Kontopidou, F. N.
    Siakantaris, M. P.
    Dimitriadou, E. M.
    Kokoris, S. I.
    Sahanas, S.
    Dimitrakopoulos, S.
    Papadaki, H. A.
    Panayiotidis, P.
    Angelopoulou, M. K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 558 - 558
12345